Literature DB >> 32620560

TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells.

Takuya Sekine1, André Perez-Potti1, Son Nguyen2,3, Jean-Baptiste Gorin1, Vincent H Wu2,3, Emma Gostick4, Sian Llewellyn-Lacey4, Quirin Hammer1, Sara Falck-Jones5, Sindhu Vangeti5, Meng Yu5, Anna Smed-Sörensen5, Ahmed Gaballa6, Michael Uhlin7,8, Johan K Sandberg1, Christian Brander9,10,11, Piotr Nowak12, Paul A Goepfert13, David A Price4,14, Michael R Betts2,3, Marcus Buggert15.   

Abstract

CD8+ T cell exhaustion is a hallmark of many cancers and chronic infections. In mice, T cell factor 1 (TCF-1) maintains exhausted CD8+ T cell responses, whereas thymocyte selection-associated HMG box (TOX) is required for the epigenetic remodeling and survival of exhausted CD8+ T cells. However, it has remained unclear to what extent these transcription factors play analogous roles in humans. In this study, we mapped the expression of TOX and TCF-1 as a function of differentiation and specificity in the human CD8+ T cell landscape. Here, we demonstrate that circulating TOX+ CD8+ T cells exist in most humans, but that TOX is not exclusively associated with exhaustion. Effector memory CD8+ T cells generally expressed TOX, whereas naive and early-differentiated memory CD8+ T cells generally expressed TCF-1. Cytolytic gene and protein expression signatures were also defined by the expression of TOX. In the context of a relentless immune challenge, exhausted HIV-specific CD8+ T cells commonly expressed TOX, often in clusters with various activation markers and inhibitory receptors, and expressed less TCF-1. However, polyfunctional memory CD8+ T cells specific for cytomegalovirus (CMV) or Epstein-Barr virus (EBV) also expressed TOX, either with or without TCF-1. A similar phenotype was observed among HIV-specific CD8+ T cells from individuals who maintained exceptional immune control of viral replication. Collectively, these data demonstrate that TOX is expressed by most circulating effector memory CD8+ T cell subsets and not exclusively linked to exhaustion.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32620560     DOI: 10.1126/sciimmunol.aba7918

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  39 in total

1.  CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade.

Authors:  Jinfei Fu; Anze Yu; Xiang Xiao; Juyu Tang; Xiongbing Zu; Wenhao Chen; Bin He
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.

Authors:  Lewis Au; Emine Hatipoglu; Marc Robert de Massy; Kevin Litchfield; Gordon Beattie; Andrew Rowan; Desiree Schnidrig; Rachael Thompson; Fiona Byrne; Stuart Horswell; Nicos Fotiadis; Steve Hazell; David Nicol; Scott T C Shepherd; Annika Fendler; Robert Mason; Lyra Del Rosario; Kim Edmonds; Karla Lingard; Sarah Sarker; Mary Mangwende; Eleanor Carlyle; Jan Attig; Kroopa Joshi; Imran Uddin; Pablo D Becker; Mariana Werner Sunderland; Ayse Akarca; Ignazio Puccio; William W Yang; Tom Lund; Kim Dhillon; Marcos Duran Vasquez; Ehsan Ghorani; Hang Xu; Charlotte Spencer; José I López; Anna Green; Ula Mahadeva; Elaine Borg; Miriam Mitchison; David A Moore; Ian Proctor; Mary Falzon; Lisa Pickering; Andrew J S Furness; James L Reading; Roberto Salgado; Teresa Marafioti; Mariam Jamal-Hanjani; George Kassiotis; Benny Chain; James Larkin; Charles Swanton; Sergio A Quezada; Samra Turajlic
Journal:  Cancer Cell       Date:  2021-10-28       Impact factor: 31.743

3.  Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.

Authors:  Laura Campisi; Shahab Chizari; Jessica S Y Ho; Anastasia Gromova; Frederick J Arnold; Lorena Mosca; Xueyan Mei; Yesai Fstkchyan; Denis Torre; Cindy Beharry; Marta Garcia-Forn; Miguel Jiménez-Alcázar; Vladislav A Korobeynikov; Jack Prazich; Zahi A Fayad; Marcus M Seldin; Silvia De Rubeis; Craig L Bennett; Lyle W Ostrow; Christian Lunetta; Massimo Squatrito; Minji Byun; Neil A Shneider; Ning Jiang; Albert R La Spada; Ivan Marazzi
Journal:  Nature       Date:  2022-06-22       Impact factor: 69.504

4.  Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia.

Authors:  David R Collins; Jonathan M Urbach; Zachary J Racenet; Umar Arshad; Karen A Power; Ruchi M Newman; Geetha H Mylvaganam; Ngoc L Ly; Xiaodong Lian; Anna Rull; Yelizaveta Rassadkina; Adrienne G Yanez; Michael J Peluso; Steven G Deeks; Francesc Vidal; Mathias Lichterfeld; Xu G Yu; Gaurav D Gaiha; Todd M Allen; Bruce D Walker
Journal:  Immunity       Date:  2021-09-07       Impact factor: 43.474

Review 5.  TCF1 in T cell immunity: a broadened frontier.

Authors:  Xudong Zhao; Qiang Shan; Hai-Hui Xue
Journal:  Nat Rev Immunol       Date:  2021-06-14       Impact factor: 53.106

Review 6.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

Review 7.  Cellular networks controlling T cell persistence in adoptive cell therapy.

Authors:  Jack D Chan; Junyun Lai; Clare Y Slaney; Axel Kallies; Paul A Beavis; Phillip K Darcy
Journal:  Nat Rev Immunol       Date:  2021-04-20       Impact factor: 53.106

8.  WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.

Authors:  Man Wu; Xueqing Xia; Jiemiao Hu; Natalie Wall Fowlkes; Shulin Li
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

9.  Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.

Authors:  J Joseph Melenhorst; Rong Fan; Zhiliang Bai; Stefan Lundh; Dongjoo Kim; Steven Woodhouse; David M Barrett; Regina M Myers; Stephan A Grupp; Marcela V Maus; Carl H June; Pablo G Camara
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

10.  TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.

Authors:  Kathrin Heim; Benedikt Binder; Dominik Wieland; Nina Hensel; Sian Llewellyn-Lacey; Emma Gostick; David A Price; Florian Emmerich; Hildegard Vingerhoet; Anke R M Kraft; Markus Cornberg; Tobias Boettler; Christoph Neumann-Haefelin; Dietmar Zehn; Bertram Bengsch; Maike Hofmann; Robert Thimme
Journal:  Gut       Date:  2020-10-23       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.